ADAG
Adagene Inc
NASDAQ: ADAG · HEALTHCARE · BIOTECHNOLOGY
$3.55
+0.57% today
Updated 2026-04-29
Market cap
$234.56M
P/E ratio
—
P/S ratio
30.58x
EPS (TTM)
$-0.37
Dividend yield
—
52W range
$1 – $5
Volume
0.3M
Adagene Inc (ADAG) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-229.60%
Operating margin
-75.00%
ROE
-34.40%
ROA
-16.00%
Debt/equity
0.18x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $1.51M | $-14.72M | 100.00% | -1,147.09% | -974.03% |
| 2019 | $480000.00 | $-17.29M | 100.00% | -3,993.68% | -3,602.89% |
| 2020 | $480000.00 | $-16.44M | 100.00% | -3,993.68% | -3,424.06% |
| 2021 | $10.18M | $-73.18M | 100.00% | -711.18% | -719.18% |
| 2022 | $9.29M | $-79.97M | 100.00% | -903.08% | -860.59% |
| 2023 | $18.11M | $-18.95M | 100.00% | -130.97% | -104.61% |
| 2024 | $103204.00 | $-33.42M | -797.49% | -34,835.42% | -32,386.45% |
| 2025 | $7.67M | $-17.61M | 100.00% | -279.48% | -229.56% |